| 1 |  LLY•US•NYSE·Options $881.67B·$906.70·-7.96% | | $881.67B | $906.70 | -7.96% | 4.8M | |
| 2 |  JNJ•US•NYSE·Options $582.04B·$235.37·-2.55% | | $582.04B | $235.37 | -2.55% | 17.2M | |
| 3 |  4AB•DE•XETRA $400.45B·$206.37·-8.88% | | $400.45B | $206.37 | -8.88% | 78 | |
| 4 |  ABBV•US•NYSE·Options $388.43B·$204.33Live·-6.65% | | $388.43B | $204.33Live | -6.65% | 350 | |
| 5 |  ROGN•MX•MX $347.95B·$420.15·-7.90% | | $347.95B | $420.15 | -7.90% | - | |
| 6 |  RO•CH•SW $332.93B·$393.30·-6.01% | | $332.93B | $393.30 | -6.01% | 139.2K | |
| 7 |  ROG•CH•SW $324.13B·$407.40·-6.01% | | $324.13B | $407.40 | -6.01% | 1.1M | |
| 8 | RH Roche Holding AG Participation RHHVF•US•OTCQX $317.75B·$395.01·-5.69% | | $317.75B | $395.01 | -5.69% | 17.2K | |
| 9 |  AZN•SE•ST $296.15B·$185.34·-2.95% | | $296.15B | $185.34 | -2.95% | 350.9K | |
| 10 |  AZN•US•NASDAQ·Options $294.40B·$183.60·-3.32% | | $294.40B | $183.60 | -3.32% | 2.1M | |
| 11 |  NOVN•CH•SW $294.18B·$146.85·-4.75% | | $294.18B | $146.85 | -4.75% | 10.9M | |
| 12 | AZ AZNCF•US•PINK $290.60B·$183.60·-3.32% | | $290.60B | $183.60 | -3.32% | 2.1M | |
| 13 | NV NVSEF•US•PINK $290.05B·$150.19·-6.24% | | $290.05B | $150.19 | -6.24% | - | |
| 14 |  ZEG•DE•XETRA $287.97B·$185.69·+0.00% | | $287.97B | $185.69 | +0.00% | - | |
| 15 |  MRK•US•NYSE·Options $285.83B·$114.18·-1.24% | | $285.83B | $114.18 | -1.24% | 36.4M | |
| 16 | MR MRK•AT•VI $285.11B·$114.63·-0.60% | | $285.11B | $114.63 | -0.60% | 82 | |
| 17 |  UnitedHealth Group Incorporated UNH•US•NYSE·Options $256.05B·$275.59·-2.30% | | $256.05B | $275.59 | -2.30% | 38.9M | |
| 18 | AM AMG•DE•XETRA $200.01B·$347.63·-6.31% | | $200.01B | $347.63 | -6.31% | 239 | |
| 19 | AM AMGN•US•NASDAQ·Options $197.41B·$349.27Live·-5.03% | | $197.41B | $349.27Live | -5.03% | 120 | |
| 20 | AB ABL•DE•XETRA $189.77B·$106.18·-2.77% | | $189.77B | $106.18 | -2.77% | 272 | |
| 21 | AB ABT•US•NYSE·Options $187.72B·$103.40Live·-2.38% | | $187.72B | $103.40Live | -2.38% | 1 | |
| 22 |  GIS•DE•XETRA $182.18B·$137.55·-6.27% | | $182.18B | $137.55 | -6.27% | 942 | |
| 23 |  Thermo Fisher Scientific Inc TMO•US•NYSE·Options $172.51B·$474.39·+2.16% | | $172.51B | $474.39 | +2.16% | 2.3M | |
| 24 |  EL•FR•PA $171.16B·$225.03·-4.86% | | $171.16B | $225.03 | -4.86% | 1.4M | |
| 25 |  NOVO-B•DK•CO $170.69B·$36.72·-3.89% | | $170.69B | $36.72 | -3.89% | 16.2M | |
| 26 | NO NOV•DE•XETRA $169.75B·$36.63·-4.11% | | $169.75B | $36.63 | -4.11% | 275.2K | |
| 27 |  DAP•DE•XETRA $134.64B·$189.99·+1.07% | | $134.64B | $189.99 | +1.07% | 274 | |
| 28 |  DHR•US•NYSE·Options $132.46B·$189.35·+1.08% | | $132.46B | $189.35 | +1.08% | 5.7M | |
| 29 |  Vertex Pharmaceuticals Inc VRTX•MX•MX $128.20B·$458.93·-3.12% | | $128.20B | $458.93 | -3.12% | 442 | |
| 30 |  Bristol-Myers Squibb Company BMY•US•NYSE·Options $121.60B·$57.48·-2.71% | | $121.60B | $57.48 | -2.71% | 65.8M | |
| 31 |  Bristol-Myers Squibb Company BRM•DE•XETRA $121.33B·$57.38·-3.69% | | $121.33B | $57.38 | -3.69% | 547 | |
| 32 | TE TEVA•IL $115.88B·$9,091.00·-1.98% | | $115.88B | $9,091.00 | -1.98% | 1.4M | |
| 33 |  2M6•DE•XETRA $115.25B·$86.59·-2.04% | | $115.25B | $86.59 | -2.04% | 791 | |
| 34 |  SAN•FR•PA $114.69B·$89.89·+1.83% | | $114.69B | $89.89 | +1.83% | 8.6M | |
| 35 | GS GS71•DE•XETRA $108.79B·$25.96·-4.38% | | $108.79B | $25.96 | -4.38% | 98.9K | |
| 36 |  SNYN•MX•MX $108.44B·$44.90·-2.38% | | $108.44B | $44.90 | -2.38% | 6 | |
| 37 |  EssilorLuxottica Société anonyme ESLOF•US•PINK $108.39B·$220.01·-5.68% | | $108.39B | $220.01 | -5.68% | 600 | |
| 38 |  GLAXF•US•PINK $108.17B·$26.08·-3.41% | | $108.17B | $26.08 | -3.41% | 100 | |
| 39 | ES ESLOY•US•PINK $107.79B·$112.00·-3.75% | | $107.79B | $112.00 | -3.75% | 102.9K | |
| 40 |  SNW•DE•XETRA $106.62B·$89.76·+1.66% | | $106.62B | $89.76 | +1.66% | 36.1K | |
| 41 |  BSX•US•NYSE·Options $102.58B·$69.48·+0.51% | | $102.58B | $69.48 | +0.51% | 20.1M | |
| 42 |  Chugai Pharmaceutical Co. Ltd CHGCF•US•PINK $98.34B·$52.24·-12.57% | | $98.34B | $52.24 | -12.57% | 900 | |
| 43 |  CVS•US•NYSE·Options $96.85B·$71.48·-6.11% | | $96.85B | $71.48 | -6.11% | 18.9M | |
| 44 |  Chugai Pharmaceutical Co Ltd ADR CHGCY•US•PINK $96.50B·$26.53·-9.02% | | $96.50B | $26.53 | -9.02% | 152.7K | |
| 45 |  CHUGAI PHARMACEUTICAL CO.,LTD. 4519•JP $87.72B·$50.05·-11.56% | | $87.72B | $50.05 | -11.56% | 4.3M | |
| 46 |  CI•US•NYSE·Options $71.37B·$262.84·-1.63% | | $71.37B | $262.84 | -1.63% | 3.8M | |
| 47 |  COR•US•NYSE·Options $68.08B·$326.91·-6.58% | | $68.08B | $326.91 | -6.58% | 3.0M | |
| 48 |  ELV•US•NYSE·Options $64.36B·$291.48·-0.05% | | $64.36B | $291.48 | -0.05% | 2.5M | |
| 49 | HO HOCPF•US•PINK $59.43B·$175.79·-5.99% | | $59.43B | $175.79 | -5.99% | - | |
| 50 |  Becton Dickinson and Company BDX•US•NYSE·Options $57.74B·$154.13·-3.28% | | $57.74B | $154.13 | -3.28% | 3.7M | |